MOTS-c Exercise Mimetic Effects
Why MOTS-c gets called an exercise mimetic: the exercise-like effects seen in mice, and why none of them has been tested in people.
Exercise Mimetic Concept
MOTS-c gets called an exercise mimetic because, in mice, it activates AMPK, an energy sensor that exercise also turns on. As of October 2026, no published study has given it to people. Our MOTS-c overview covers the peptide itself.
Definition
| Aspect | Description |
|---|---|
| Exercise mimetic | Compound replicating some exercise signals |
| MOTS-c mechanism | AMPK activation |
| Research stage | Mice and cells only |
MOTS-c Exercise-Like Effects
Metabolic Effects
| Effect | Exercise | MOTS-c (mice) | Tested in people? |
|---|---|---|---|
| AMPK activation | Strong | Yes | No |
| Glucose uptake | Increased | Increased | No |
| Fat oxidation | Increased | Increased | No |
| Insulin sensitivity | Improved | Improved | No |
The glucose and lipid mechanisms are covered in how MOTS-c regulates metabolism. An effect on mitochondrial biogenesis hasn't been established.
Research Findings
Animal Studies
| Finding | Model | Significance |
|---|---|---|
| Obesity prevention | Mice | Metabolic protection |
| Insulin sensitivity | Aged and high-fat-fed mice | Metabolic protection |
| Exercise capacity | Young to old mice | Longer treadmill runs |
In a 2021 study, old mice given MOTS-c ran about twice as long as untreated old mice. Two authors consulted for CohBar, which was developing a MOTS-c analog. Our MOTS-c endurance article covers those results.
Human Research
| Study Type | Status | Findings |
|---|---|---|
| Exercise correlation | One small study | Rises with exercise |
| Direct supplementation | None published | No human data |
| Analog (CB4211) | Discontinued | Development ended in 2023 |
That 2021 paper measured the body's own MOTS-c in sedentary young men who cycled: muscle levels rose about 11.9-fold and blood levels about 1.5-fold. That doesn't show that injecting MOTS-c reproduces exercise.
Practical Considerations
Current Limitations
| Factor | Reality |
|---|---|
| Human data | No administration studies |
| Optimal dosing | Unknown |
| Long-term effects | Unstudied |
WADA's 2026 Prohibited List names MOTS-c under S4.4.1, next to AICAR, as a non-Specified substance prohibited at all times.
Exercise Comparison
"Mimetic" overstates it. MOTS-c overlaps with one signaling route in mice, while exercise acts on the whole body in people.
| Factor | Exercise | MOTS-c |
|---|---|---|
| Overall health | Comprehensive | Metabolic focus |
| Cardiovascular | Direct benefits | Not studied |
| Muscle strength | Direct | Not shown |
| Evidence | Extensive | Mice only |
What We Still Don't Know
No completed study has tested whether giving MOTS-c to a person changes anything exercise changes, and the safety of repeated injections is unknown.
Stay Updated on Peptide Research
Get weekly breakdowns of new studies, dosing insights, and community protocols. No spam, unsubscribe anytime.
References
- The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance (Cell Metabolism, 2015)
- MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis (Nature Communications, 2021)
- CohBar filing on CB4211 formulation (SEC, 2023)
- CohBar Form 8-K on merger termination and planned liquidation (SEC, November 2023)
- World Anti-Doping Agency 2026 Prohibited List (WADA, 2025)